CALGARY, ALBERTA--(Marketwire - July 07, 2008) - Stem Cell Therapeutics Corp. (“SCT”) (TSX VENTURE: SSS) is pleased to announce the Company has been issued two corresponding patents to strengthen its intellectual property landscape through United States and Australia.
